Cambridge, MA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)SECUREBIO INC, founded in 2022, is a community nonprofit in the Science & Technology sector that reported $7.3M in total revenue in fiscal year 2024. Revenue surged 70% from the prior year, signaling strong growth momentum. The organization ran a surplus of $3.1M, a strong 42% operating margin.
To reduce catastrophic risks from novel biotechnologies by conducting research on pandemic prevention, detection, and mitigation.
As part of its work on the Nucleic Acid Observatory NAO project, the organization runs experiments to detect metagenomic sequences in wasterwater, with the ultimate aim of detecting new diseases...
As part of its work on the Nucleic Acid Observatory NAO project, the organization runs experiments to detect metagenomic sequences in wasterwater, with the ultimate aim of detecting new diseases before they grow exponentially in the community. In 2024, The NAO team conducted real-world biosurveillance of metropolitan sewage and airplane wastewater samples from selected US airports. It expects to scale its detection efforts in 2025.
As part of its SecureDNA project, the organization continued to make significant progress in 2024 on its gene synthesis screening software. The team released an alpha version and prepared for a...
As part of its SecureDNA project, the organization continued to make significant progress in 2024 on its gene synthesis screening software. The team released an alpha version and prepared for a public beta launch. This free software offers best-in-class performance in screening criteria and runs against a continuously updated hazard database. SecureDNA uniquely integrates with both vendor order flows and benchtop synthesizers. The organization successfully tested with major manufacturers and collaborated with leading gene synthesis companies. Two papers were prepared for submission to peer-reviewed journals, one on the screening system and another on its cryptographic architecture. These advancements further the organization's goal of securely monitoring synthetic DNA orders against various public health hazards.
The organization is developing measurement tools to assess AI systems' potential contribution to global catastrophic biological risks and creating mitigation strategies for when AI capabilities cross...
The organization is developing measurement tools to assess AI systems' potential contribution to global catastrophic biological risks and creating mitigation strategies for when AI capabilities cross specific risk thresholds. Working with government and industry partners, they aim to de-risk upcoming AI model releases against severe biological hazards. The team has already published a pre-print on biorisks associated with model weight proliferation in Large Language Models, garnering major media attention. Their ongoing projects include research on risks from frontier models, developing benchmarks to evaluate large language models' biosecurity-relevant capabilities, creating task-based assessments for frontier systems' autonomous capabilities, and implementing technical interventions for risk mitigation, such as model unlearning of dual-use biological concepts and enhancing adversarial robustness against dual-use input prompts.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $7,324,329 | $4,319,125 | +0.7% |
| Expenses | $4,251,865 | $2,853,790 | +0.5% |
| Net Income | $3,072,464 | $1,465,335 | +1.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Jeffrey Kaufman | NAO Project Lead | 40.00 |
|
$145,000 | $6,815 | $151,815 |
| Michael McLaren | Research Scientist | 40.00 |
|
$138,299 | $12,116 | $150,415 |
| William Bradshaw | Secretary | 40.00 |
Officer
|
$121,513 | $10,347 | $131,860 |
| Seth Donoughe | Research Scientist | 40.00 |
|
$122,747 | $4,225 | $126,972 |
| Daniel Rice | Research Scientist | 40.00 |
|
$113,672 | $5,207 | $118,879 |
| Benjamin Mueller Treas Sep-Dec | Executive Dir. | 15.00 |
Officer
Director
|
$53,175 | $0 | $53,175 |
| Vaishnav Sunil Treas Jan-Sep | Treasurer | 15.00 |
Officer
|
$24,397 | $526 | $24,923 |
| Kevin Esvelt | Director | 0.50 |
Director
|
$0 | $0 | $0 |
| Sawyer Bernath | Director | 2.00 |
Director
|
$0 | $0 | $0 |
| Liv Boeree | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Michael Specter | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Christine Parthemore | Director | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $7,324,329 | $4,251,865 | $8,470,365 | $3,072,464 |
| 2023 | $4,319,125 | $2,853,790 | $4,855,240 | $1,465,335 |
| 2023 | $4,319,125 | $2,853,790 | $4,855,240 | $1,465,335 |
| 2022 | $3,436,133 | $186,279 | $3,261,854 | $3,249,854 |
Compare SECUREBIO INC with other nonprofits in Massachusetts and across the country.